文献速递重症综合管理与镇静镇痛儿科与产科急症

危重儿童串联体外血液净化/支持治疗:文献综述

Tandem Extracorporeal Blood Purification/Support Therapies in Critically Ill Children: A Literature Review.
PubMed 文献 · Crit Care Med · 2025-11-21
一句话结论危重儿童串联体外血液净化/支持治疗可减少操作停机时间、优化血管通路,但方案异质、超说明书使用且低钙血症与血流动力学不稳定风险增加。

本文综述危重儿童中串联体外血液净化/支持治疗(EBP/ST)的现有证据、临床指征、方法学、结局与挑战。串联EBP/ST越来越多用于脓毒症诱导的多器官衰竭、急性肝衰竭和血小板减少相关多器官功能障碍综合征等复杂疾病。其益处包括减少操作停机时间、优化血管通路和提高治疗效率,但串联治疗仍属超说明书使用,临床方案差异大,缺乏儿童特异性指南,低钙血症和血流动力学不稳定等并发症风险增加,限制其广泛采用。作者认为制定标准化指南、加强多学科培训和建立多中心登记可能有助于优化其安全有效使用。

要点

  • 串联EBP/ST用于脓毒症诱导的多器官衰竭、急性肝衰竭和血小板减少相关多器官功能障碍综合征等危重儿童。
  • 益处包括减少操作停机时间、优化血管通路和提高治疗效率。
  • 串联EBP/ST仍属超说明书使用,临床方案差异大,缺乏儿童特异性指南。
  • 并发症风险包括低钙血症和血流动力学不稳定,限制其广泛采用。
  • 作者认为制定标准化指南、加强多学科培训和建立多中心登记可能有助于优化其安全有效使用。

适用人群与场景

  • 危重儿童,包括脓毒症诱导的多器官衰竭、急性肝衰竭和血小板减少相关多器官功能障碍综合征患儿。
  • 纳入描述儿童串联使用EBP/ST的研究,包括病例系列、观察性研究和专家综述。
  • 排除仅关注成人人群或单一模式治疗的研究。

研究设计与关键结果

  • 本文为文献综述,纳入描述儿童串联使用EBP/ST的病例系列、观察性研究和专家综述。
  • 串联EBP/ST越来越多用于脓毒症诱导的多器官衰竭、急性肝衰竭和血小板减少相关多器官功能障碍综合征等复杂疾病。
  • 益处包括减少操作停机时间、优化血管通路和提高治疗效率。
  • 串联治疗仍属超说明书使用,临床方案差异大,缺乏儿童特异性指南,低钙血症和血流动力学不稳定等并发症风险增加,限制其广泛采用。

证据类型、等级与局限

  • 证据类型:文献综述,纳入病例系列、观察性研究和专家综述。
  • 局限:串联EBP/ST仍属超说明书使用,临床方案差异大,缺乏儿童特异性指南。
  • 局限:并发症风险包括低钙血症和血流动力学不稳定,限制其广泛采用。

对床旁实践的改变

  • 作者认为,制定标准化指南、加强多学科培训和建立多中心登记可能有助于优化危重儿童中串联EBP/ST的安全有效使用。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: To evaluate the current evidence, clinical indications, methodologies, outcomes, and challenges associated with tandem extracorporeal blood purification/support therapies (EBP/STs) in critically ill children.

DATA SOURCES: A literature review of peer-reviewed articles, clinical guidelines, and existing literature related to continuous renal replacement therapy, therapeutic plasma exchange, extracorporeal membrane oxygenation, and their concurrent use in critically ill children.

STUDY SELECTION: Studies were included if they described tandem use of EBP/ST modalities in children, including case series, observational studies, and expert reviews. Studies focusing exclusively on adult populations or single modality therapy were excluded.

DATA EXTRACTION: Key data points extracted were patient population, clinical indication for tandem therapy, type and sequence of EBP/ST modality used, reported outcomes, and complications. Emphasis was placed on child-specific applications, safety profiles, and treatment protocols.

DATA SYNTHESIS: Tandem EBP/ST are increasingly used to treat children with complex conditions such as sepsis-induced multiple organ failure, acute liver failure, and thrombocytopenia-associated multiple organ dysfunction syndrome. This review synthesizes the reported risks, benefits, and proposed protocols for tandem therapy use in PICUs. Benefits include reduced procedural downtime, optimized vascular access, and enhanced therapeutic efficiency. However, tandem therapies remain off-label, with widely variable clinical protocols, lack of children-specific guidelines, and increased risk of complications such as hypocalcemia and hemodynamic instability, limiting their widespread adoption.

CONCLUSIONS: Tandem EBP/STs remain an emerging but incompletely standardized intervention in pediatric critical care. While they offer potential benefits such as improved procedural efficiency and reduced vascular access requirements, their use is limited by heterogeneous protocols, off-label application, and risk of complications. Efforts toward developing standardized guidelines, enhancing multidisciplinary training, and establishing multicenter registries may help optimize their safe and effective use in critically ill children.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Shirode P, Beck T, Fuhrman DY, et al. Tandem Extracorporeal Blood Purification/Support Therapies in Critically Ill Children: A Literature Review. Crit Care Med. 2025. PMID: 41489340. doi:10.1097/CCM.0000000000006939

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。